All that talk about re-investing in Britain has paid off. GlaxoSmithKline ($GSK) CEO Andrew Witty (photo) was honored with a knighthood over New Year's after he promised increased spending on domestic facilities, staff and development. GSK's discounted pricing in poor countries must have helped, too. Report